MedTrace Logo

Development and Validation of a Screening Score for the Biliary Atresia in Infantile Cholestasis: A Prospective Study

NCT03842150 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-12-28

No results posted yet for this study

Summary

Better survival and prognosis of biliary atresia (BA) depend on early diagnosis and timely Kasai portoenterostomy. Identifying BA from other causes of infantile cholestasis at early stage of the disease still remains a major challenge. In this study, the investigators aim to develop and validate a scoring system to screen BA in infants with cholestasis.

Conditions

  • Biliary Atresia
  • Neonatal Cholestasis
  • Infantile Hepatitis Syndrome

Interventions

DIAGNOSTIC_TEST

biliary atresia screen score

The investigators aim to develop a scoring system according to clinical, laboratory, imaging features of biliary atresia in the derivation dataset and tested in the validation datasets.

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
3 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03842150 on ClinicalTrials.gov